Clinical Trial: Singapore - Malaysia - Shanghai Kidney Trial - Nephrotic Syndrome (SMART-NS): Dulepivoumab for maintenance treatment of steroid-dependent and frequently relapsing nephrotic syndrome (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Singapore - Malaysia - Shanghai Kidney Trial - Nephrotic Syndrome (SMART-NS): Dulepivoumab for maintenance treatment of steroid-dependent and frequently relapsing nephrotic syndrome'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130430

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Children's Hospital of Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337513

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Singapore - Malaysia - Shanghai Kidney Trial - Nephrotic Syndrome (SMART-NS): Dulepivoumab for maintenance treatment of steroid-dependent and frequently relapsing nephrotic syndrome (China)